Herrick-Davis K - Search Results

1

Modulation of neurite outgrowth in neuroblastoma cells by protein kinase C and platelet-activating factor.

Herrick-Davis K, Camussi G, Bussolino F, Baglioni C. Herrick-Davis K, et al. J Biol Chem. 1991 Oct 5;266(28):18620-5. J Biol Chem. 1991. PMID: 1917984 Free article.

2

Inhibition of the synthesis of platelet-activating factor by anti-inflammatory peptides (antiflammins) without methionine.

Tetta C, Camussi G, Bussolino F, Herrick-Davis K, Baglioni C. Tetta C, et al. J Pharmacol Exp Ther. 1991 May;257(2):616-20. J Pharmacol Exp Ther. 1991. PMID: 2033508

3

Activating mutations of the serotonin 5-HT2C receptor.

Herrick-Davis K, Egan C, Teitler M. Herrick-Davis K, et al. J Neurochem. 1997 Sep;69(3):1138-44. doi: 10.1046/j.1471-4159.1997.69031138.x. J Neurochem. 1997. PMID: 9282936 Free article.

4

Serotonin 5-HT2C receptor RNA editing alters receptor basal activity: implications for serotonergic signal transduction.

Herrick-Davis K, Grinde E, Niswender CM. Herrick-Davis K, et al. J Neurochem. 1999 Oct;73(4):1711-7. doi: 10.1046/j.1471-4159.1999.731711.x. J Neurochem. 1999. PMID: 10501219 Free article.

5

Pharmacological characterization of the constitutively activated state of the serotonin 5-HT2C receptor.

Herrick-Davis K, Grinde E, Gauthier C, Teitler M. Herrick-Davis K, et al. Ann N Y Acad Sci. 1998 Dec 15;861:140-5. doi: 10.1111/j.1749-6632.1998.tb10185.x. Ann N Y Acad Sci. 1998. PMID: 9928251

6

Creation of a constitutively activated state of the 5-hydroxytryptamine2A receptor by site-directed mutagenesis: inverse agonist activity of antipsychotic drugs.

Egan CT, Herrick-Davis K, Teitler M. Egan CT, et al. J Pharmacol Exp Ther. 1998 Jul;286(1):85-90. J Pharmacol Exp Ther. 1998. PMID: 9655845

7

Detection of a novel serotonin receptor subtype (5-HT1E) in human brain: interaction with a GTP-binding protein.

Leonhardt S, Herrick-Davis K, Titeler M. Leonhardt S, et al. J Neurochem. 1989 Aug;53(2):465-71. doi: 10.1111/j.1471-4159.1989.tb07357.x. J Neurochem. 1989. PMID: 2664084

8

Agonist high and low affinity state ratios predict drug intrinsic activity and a revised ternary complex mechanism at serotonin 5-HT(2A) and 5-HT(2C) receptors.

Egan C, Grinde E, Dupre A, Roth BL, Hake M, Teitler M, Herrick-Davis K. Egan C, et al. Synapse. 2000 Feb;35(2):144-50. doi: 10.1002/(SICI)1098-2396(200002)35:2<144::AID-SYN7>3.0.CO;2-K. Synapse. 2000. PMID: 10611640

9

Creation of a constitutively activated state of the 5-HT2A receptor by site-directed mutagenesis: revelation of inverse agonist activity of antagonists.

Egan C, Herrick-Davis K, Teitler M. Egan C, et al. Ann N Y Acad Sci. 1998 Dec 15;861:136-9. doi: 10.1111/j.1749-6632.1998.tb10184.x. Ann N Y Acad Sci. 1998. PMID: 9928250

10

[3H]spiroxatrine: a 5-HT1A radioligand with agonist binding properties.

Herrick-Davis K, Titeler M. Herrick-Davis K, et al. J Neurochem. 1988 Feb;50(2):528-33. doi: 10.1111/j.1471-4159.1988.tb02943.x. J Neurochem. 1988. PMID: 2961850

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters